Browse By: Country ι Category ι Latest Reports ι Tag

Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail

Pages » 72
Published By » GBI Research
Price » $3500
In stock
View Report Details
Description

Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail Summary Leading business intelligence provider, GBI Research, has released its latest research report, entitled: “Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail”. The report provides insights into the liver cancer therapeutics market in the US, the top five European countries (the UK, Germany, France, Italy and Spain) and Japan, with market forecasts until 2018. It provides in-depth analysis of the... Click here for more details


Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020
GlobalData\'s pharmaceutical report, Prostate Cancer Brazil, Russia, India and China (BRIC) Drug Forecasts and Treatment Analysis to 2020 is an essential source of information and analysis on the prostate cancer therapeutics market in the emerging BRIC countries. The report provides comprehensiv
Published Date: Dec 2010
Price: $3000
Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020
GlobalData\'s pharmaceutical report, Prostate Cancer US Drug Forecasts and Treatment Analysis to 2020 is an essential source of information and analysis on the US prostate cancer therapeutics market. The report provides comprehensive information on prostate cancer, highlighting the treatment gui
Published Date: Dec 2010
Price: $3000
Prostate Cancer - France Drug Forecasts and Treatment Analysis to 2020
GlobalData\'s pharmaceutical report, Prostate Cancer France Drug Forecasts and Treatment Analysis to 2020 is an essential source of information and analysis on the French prostate cancer therapeutics market. The report provides comprehensive information on prostate cancer, highlighting the treat
Published Date: Dec 2010
Price: $3000
Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020
GlobalData\'s pharmaceutical report, Prostate Cancer Spain Drug Forecasts and Treatment Analysis to 2020. The report is an essential source of information and analysis on the Spanish prostate cancer therapeutics market. The report provides comprehensive information on prostate cancer, highlighti
Published Date: Dec 2010
Price: $3000
Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020
GlobalData\'s pharmaceutical report, Prostate Cancer Italy Drug Forecasts and Treatment Analysis to 2020. The report is an essential source of information and analysis on the Italian prostate cancer therapeutics market. The report provides comprehensive information on prostate cancer, highlighti
Published Date: Dec 2010
Price: $3000
Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020
GlobalData\'s pharmaceutical report, Prostate Cancer Japan Drug Forecasts and Treatment Analysis to 2020 is an essential source of information and analysis on the Japanese prostate cancer therapeutics market. The report provides comprehensive information on prostate cancer, highlighting the trea
Published Date: Dec 2010
Price: $3000
Castration Resistant Prostate Cancer: Clinical Insights from a US Oncologists\' Survey
Progressively unfolding patient situation, presented to 154 oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment and testing choices, factors that influence their decisions, barriers to optimal treatment a
Published Date: Mar 2011
Price: $2999
Prostate Cancer - Pipeline Assessment and Market Forecasts to 2020
GlobalData, the industry analysis specialist, has released its new report, “Prostate Cancer - Pipeline Assessment and Market Forecasts to 2020”. The report is an essential source of information and analysis on the global prostate cancer therapeutics market. The report provides detailed
Published Date: Dec 2010
Price: $3500
Sarcomas Global Clinical Trials Review, Q4, 2010
GlobalData's clinical trial report, Sarcomas Global Clinical Trials Review, Q4, 2010" provides data on the Sarcomas clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Sarcomas. It includes an overview of the trial numbers and their recrui
Published Date: Dec 2010
Price: $1000
Carcinomas Global Clinical Trials Review, Q4, 2010
GlobalData's clinical trial report, Carcinomas Global Clinical Trials Review, Q4, 2010" provides data on the Carcinomas clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Carcinomas. It includes an overview of the trial numbers and their
Published Date: Dec 2010
Price: $1000

 


 

Related News

After Louisiana-Pacific’s Downgrade - What’s next in the Building and Construction Products Industry?
Louisiana-Pacific Corporation was downgraded by the DA Davidson research firm last Friday from a status of “Buy” to a “Neutral” rating, i.e. LPX 0%. RBC Capital had struck a similar rating a few days earlier. It changed its rating from ‘Sector Perform’ to ‘Underperform’ - where the price target was set as $13.00 per share. These implications apply a downside potential of 22 percent from the present price (as of December 8) of $16.85 per share. 
Date: Dec 09

Vasinee Food Corp. and Thai Agri Food Co. Launch FOCO, a 100% Pure Coconut Water
Vasinee Food Corp., one of the largest U.S. wholesale food distributor and a leading importer of Thai and Asian food products and Thai Agri Food Co. a Thailand based food processing company, have launched FOCO, a popular new beverage categorized as 100% pure coconut water in the United States. These two companies have been producing and selling FOCO coconut juice and other coconut products in the U.S. for more than 25 years and now FOCO is the leading brand in the ethnic market. The shift to coc
Date: Sep 26

Upcoming Reports

Oncology Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
Oncology is the study of Cancer. Oncology devices market consists of medical devices involved in diagnosing and treating the disease cancer. The Oncology devices market could be segmented into 2 major categories: by type and by applications. There are two types of Brachytherapy devices and the E
Published By: Transparency Market Research
Price: $4595
Biologicals In Oncology Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Biological therapy is defined as use of living organisms and substances derived from organism or synthetically produced version of such substances in laboratories to treat the disease condition. Some of the biological therapies for cancer involve vaccines or bacteria to stimulate the body’s de
Published By: Transparency Market Research
Price: $4795